Stocks and Investing Stocks and Investing
Thu, March 17, 2022

Reni Benjamin Maintained (ACET) at Buy with Decreased Target to $21 on, Mar 17th, 2022


Published on 2024-10-27 20:07:01 - WOPRAI, Reni Benjamin
  Print publication without navigation


Reni Benjamin of JMP Securities, Maintained "Adicet Bio, Inc." (ACET) at Buy with Decreased Target from $30 to $21 on, Mar 17th, 2022.

Reni has made no other calls on ACET in the last 4 months.



There are 3 other peers that have a rating on ACET. Out of the 3 peers that are also analyzing ACET, 0 agree with Reni's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Reni


  • Asthika Goonewardene of "Truist Securities" Initiated at Strong Buy and Held Target at $30 on, Tuesday, March 8th, 2022
  • Kelly Shi of "Jefferies" Initiated at Strong Buy and Held Target at $27 on, Friday, March 4th, 2022
  • Michael Schmidt of "Guggenheim" Maintained at Strong Buy with Increased Target to $32 on, Monday, December 6th, 2021
Contributing Sources